NEUROCRINE BIOSCIENCES INC Annual Income Tax Expense (Benefit) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Neurocrine Biosciences Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
  • Neurocrine Biosciences Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $60.5M, a 86.2% increase year-over-year.
  • Neurocrine Biosciences Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $136M, a 123% increase year-over-year.
  • Neurocrine Biosciences Inc annual Income Tax Expense (Benefit) for 2023 was $82.4M, a 38.7% increase from 2022.
  • Neurocrine Biosciences Inc annual Income Tax Expense (Benefit) for 2022 was $59.4M, a 403% increase from 2021.
  • Neurocrine Biosciences Inc annual Income Tax Expense (Benefit) for 2021 was $11.8M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $82.4M +$23M +38.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-09
2022 $59.4M +$47.6M +403% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-09
2021 $11.8M +$312M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-09
2020 -$301M -$310M -3264% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $9.5M +$8.8M +1257% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 $700K +$700K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-05
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-02-08
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-08
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-13
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-02-14
2013 $0 $0 Jan 1, 2013 Dec 31, 2013 10-K 2016-02-11
2012 $0 $0 Jan 1, 2012 Dec 31, 2012 10-K 2015-02-09
2011 $0 Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.